Hodel F, De Min M, Thorball C, Redin C, Vollenweider P, Girardin F
Clin Transl Sci. 2024; 17(9):e70009.
PMID: 39263940
PMC: 11391267.
DOI: 10.1111/cts.70009.
Jarvis J, Megill S, Silvester P, Shaman J
Camb Prism Precis Med. 2024; 1:e3.
PMID: 38550951
PMC: 10953741.
DOI: 10.1017/pcm.2022.3.
El Hadad J, Schreiner P, Vavricka S, Greuter T
Mol Diagn Ther. 2023; 28(1):27-35.
PMID: 37847439
PMC: 10787003.
DOI: 10.1007/s40291-023-00678-7.
Haga S
Pharmacy (Basel). 2023; 11(5).
PMID: 37736916
PMC: 10514841.
DOI: 10.3390/pharmacy11050144.
Decaix T, Magny R, Gouin-Thibaut I, Delavenne X, Mismetti P, Salem J
Clin Transl Sci. 2023; 16(10):1935-1946.
PMID: 37529981
PMC: 10582668.
DOI: 10.1111/cts.13601.
From gene to dose: Long-read sequencing and *-allele tools to refine phenotype predictions of .
Graansma L, Zhai Q, Busscher L, Menafra R, van den Berg R, Kloet S
Front Pharmacol. 2023; 14:1076574.
PMID: 36937863
PMC: 10014917.
DOI: 10.3389/fphar.2023.1076574.
Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota.
Zhang L, Jacobson P, Johnson A, Gregornik D, Johnson S, McCarty C
J Pers Med. 2022; 12(10).
PMID: 36294754
PMC: 9604616.
DOI: 10.3390/jpm12101615.
Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients.
Jaramillo-Valverde L, Levano K, Tarazona D, Vasquez-Dominguez A, Toledo-Nauto A, Capristano S
Int J Mol Sci. 2022; 23(19).
PMID: 36232322
PMC: 9569635.
DOI: 10.3390/ijms231911028.
Cost-Effectiveness of Pharmacogenomics-Guided Prescribing to Prevent Gene-Drug-Related Deaths: A Decision-Analytic Model.
van der Wouden C, Marck H, Guchelaar H, Swen J, van den Hout W
Front Pharmacol. 2022; 13:918493.
PMID: 36120299
PMC: 9477094.
DOI: 10.3389/fphar.2022.918493.
Pharmacogenomics Informs Cardiovascular Pharmacotherapy.
Babayeva M, Azzi B, Loewy Z
Methods Mol Biol. 2022; 2547:201-240.
PMID: 36068466
DOI: 10.1007/978-1-0716-2573-6_9.
Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?.
Lopes J, Harris K, Karow M, Peterson S, Kluge M, Kotzer K
J Mol Diagn. 2022; 24(3):253-261.
PMID: 35041929
PMC: 8961466.
DOI: 10.1016/j.jmoldx.2021.11.008.
Pharmacogenomic analysis of a genetically distinct Indigenous population.
Shankar A, Jadhao S, Hoy W, Foote S, Patel H, Scaria V
Pharmacogenomics J. 2021; 22(2):100-108.
PMID: 34824386
DOI: 10.1038/s41397-021-00262-4.
Fundamental Biomaterial Considerations in the Development of a 3D Model Representative of Primary Open Angle Glaucoma.
Lamont H, Masood I, Grover L, El Haj A, Hill L
Bioengineering (Basel). 2021; 8(11).
PMID: 34821713
PMC: 8615171.
DOI: 10.3390/bioengineering8110147.
Annotation of 1350 Common Genetic Variants of the 19 ALDH Multigene Family from Global Human Genome Aggregation Database (gnomAD).
Chen C, Kraemer B, Lee L, Mochly-Rosen D
Biomolecules. 2021; 11(10).
PMID: 34680056
PMC: 8533364.
DOI: 10.3390/biom11101423.
A Decade of Pharmacogenetic Studies in Jordan: A Systemic Review.
Yehya A, Altaany Z
Pharmacogenomics J. 2021; 21(5):543-550.
PMID: 33850297
DOI: 10.1038/s41397-021-00236-6.
Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.
Zhu Y, Lopes G, Bielinski S, Borah B, Larson N, Moyer A
Mayo Clin Proc Innov Qual Outcomes. 2021; 5(1):35-45.
PMID: 33718782
PMC: 7930862.
DOI: 10.1016/j.mayocpiqo.2020.08.009.
DRIM: A Web-Based System for Investigating Drug Response at the Molecular Level by Condition-Specific Multi-Omics Data Integration.
Oh M, Park S, Lee S, Lee D, Lim S, Jeong D
Front Genet. 2020; 11:564792.
PMID: 33281870
PMC: 7689278.
DOI: 10.3389/fgene.2020.564792.
Pharmacogenomic Biomarkers and Their Applications in Psychiatry.
Kam H, Jeong H
Genes (Basel). 2020; 11(12).
PMID: 33266292
PMC: 7760818.
DOI: 10.3390/genes11121445.
COVID19 Drug Repository: text-mining the literature in search of putative COVID19 therapeutics.
Tworowski D, Gorohovski A, Mukherjee S, Carmi G, Levy E, Detroja R
Nucleic Acids Res. 2020; 49(D1):D1113-D1121.
PMID: 33166390
PMC: 7778969.
DOI: 10.1093/nar/gkaa969.
Pharmacogenomics and Cardiovascular Disease: Where are We and Where do We go from Here?.
Stein R, Beuren T, Cela L, Ferrari F
Arq Bras Cardiol. 2020; 115(4):690-700.
PMID: 33111871
PMC: 8386961.
DOI: 10.36660/abc.20200151.